Valeritas Holdings (NASDAQ:VLRX) is poised to add to yesterday’s rally, up 7% premarket on average volume. This morning it reaffirmed its Q2 revenue outlook of $7.4M – 7.6M and $31.0M – 34.0M for the year.
Shares jumped 35% yesterday in response to updated American Diabetes Association standards of care that includes a “disposable patch-like device” like V-Go.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.